GlassScriptPhysician profile
Nabeel Saghir
NPI 1417487323
$49,010.83
in general payments reported to CMS, 2019-2025
21 companies · $17K in 2025
The $17K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,132 · 2022: $10K · 2023: $4,863 · 2024: $12K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $18K · Food and Beverage: $11K · Grant: $5,000 · Education: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $17,585.61 |
| Food and Beverage | $10,578.89 |
| Grant | $5,000.00 |
| Education | $364.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $15,932.15 | 2023-2025 | Advisa Dr Mri Surescan, Affera Mapping System, Linq II |
| Abbott Laboratories | $13,391.84 | 2021-2025 | Aveir, Quadra Assura, Nc Trek Neo |
| Boston Scientific Corporation | $11,521.64 | 2024-2025 | Farapulse, Watchman Access System, Emblem Mri S-Icd |
| Biotronik INC. | $3,217.41 | 2021-2025 | Acticor 7 Vr-T Dx |
| Biosense Webster, INC. | $931.73 | 2022-2025 | Carto 3 |
| Abiomed | $702.77 | 2021-2024 | Impella |
| Medical Device Business Services, INC. | $515.94 | 2024 | Carto 3 |
| Amgen INC. | $470.60 | 2021-2023 | Repatha |
| Pfizer INC. | $386.15 | 2022-2023 | |
| Aop Health US, LLC | $349.49 | 2025 | Rapiblyk |
| E.R. Squibb & Sons, L.L.C. | $322.46 | 2021-2023 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $216.06 | 2021-2024 | Lifevest |
| Impulse Dynamics (USA) INC. | $198.88 | 2023-2024 | Optimizer, Optimizer |
| Kestra Medical Technology Services, INC. | $159.97 | 2022-2025 | Assure Wcd |
| Cardiovascular Systems INC. | $139.50 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $137.38 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $129.53 | 2024 | Arcalyst |
| Janssen Scientific Affairs, LLC | $113.71 | 2024 | Xarelto |
| Itamar Medical INC | $103.73 | 2023 | Watchpatone |
| Astrazeneca Pharmaceuticals LP | $50.84 | 2022-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $19.05 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nabeel Saghir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.